Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 472.45
+8.35 (1.80%)
Nov 12, 2026, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 180.76 billion as of November 12, 2026. It is the 6,855th most valuable company in the world and the 401st biggest in India. Its market cap has decreased by 31.63% in one year.
Market Cap
180.76B
Enterprise Value
183.06B
Revenue
20.57B
Global Rank
Country Rank
#401 India
PE Ratio
384.31
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 180.76B, an increase of 536,194.65%. That is a compound annual growth rate of 261.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 180.45B | -10.77% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 417.78B |
| Wockhardt | 330.10B |
| Piramal Pharma | 327.49B |
| Alembic Pharmaceuticals | 199.96B |
| Alivus Life Sciences | 181.01B |
| Eris Lifesciences | 174.19B |
| NATCO Pharma | 157.79B |
| Sudeep Pharma | 136.70B |